Related Experiment Video
Updated: Jun 26, 2026

13:47
Lentiviral Vector Platform for the Efficient Delivery of Epigenome-editing Tools into Human Induced Pluripotent Stem Cell-derived Disease Models
Published on: March 29, 2019
Increased potency and longevity of gene silencing using validated Dicer substrates
1Bio-Rad Laboratories, Inc., Hercules, CA 94547, USA. eli_hefner@bio-rad.com
Journal of Biomolecular Techniques : JBT
|January 13, 2009
Summary
Chemically synthesized small interfering RNAs (siRNAs) offer gene silencing potential. Optimized Dicer-substrate 27mers provide more potent and sustained gene silencing than 21mer siRNAs, especially at lower concentrations.
Area of Science:
- Molecular Biology
- RNA Interference (RNAi)
Background:
- Small interfering RNAs (siRNAs) are key tools for gene silencing in research and therapeutics.
- The RNAi pathway utilizes double-stranded RNAs to trigger gene expression knockdown.
- Optimized Dicer-substrate 27mers are designed for efficient guide strand selection by Dicer.
Purpose of the Study:
- To compare the gene silencing efficacy of Dicer-substrate 27mers against traditional 21mer siRNAs.
- To evaluate the potency and duration of gene silencing mediated by 27mer RNAs.
Main Methods:
- Chemically synthesized 27mer Dicer-substrate RNAs and 21mer siRNAs were designed with identical guide strands.
- Gene silencing was assessed for four target genes using both RNA formats.
- Comparative analysis of silencing potency and duration was performed.
Main Results:
- Dicer-substrate 27mers demonstrated more potent gene silencing compared to 21mer siRNAs.
- The 27mer RNAs provided more sustained gene silencing across the tested genes.
- Enhanced silencing by 27mers was frequently observed at lower concentrations.
Conclusions:
- Optimized Dicer-substrate 27mers represent an advancement over 21mer siRNAs for gene silencing applications.
- These longer RNAs offer improved potency and duration, with enhanced efficacy at reduced concentrations.
- 27mer RNAs hold significant promise for both basic research and therapeutic gene silencing strategies.
Related Concept Videos
Experimental RNAi
RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
siRNA - Small Interfering RNAs
Small interfering RNAs, or siRNAs, are short regulatory RNA molecules that can silence genes post-transcriptionally, as well as the transcriptional level in some cases. siRNAs are important for protecting cells against viral infections and silencing transposable genetic elements.
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the ATP-dependent...
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the ATP-dependent...
RNA Interference
RNA interference (RNAi) is a process in which a small non-coding RNA molecule blocks the post-transcriptional expression of a gene by binding to its messenger RNA (mRNA) and preventing the protein from being translated.
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...

